NYSE:DNMR Danimer Scientific (DNMR) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free DNMR Stock Alerts $1.09 -0.04 (-3.54%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$1.07▼$1.1650-Day Range$0.61▼$1.7052-Week Range$0.60▼$4.59Volume605,534 shsAverage Volume941,214 shsMarket Capitalization$111.22 millionP/E RatioN/ADividend YieldN/APrice Target$4.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Danimer Scientific alerts: Email Address Danimer Scientific MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside267.0% Upside$4.00 Price TargetShort InterestBearish20.87% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.52) to ($1.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.98 out of 5 starsIndustrial Products Sector133rd out of 173 stocksPlastics Materials & Resins Industry10th out of 11 stocks 3.5 Analyst's Opinion Consensus RatingDanimer Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.00, Danimer Scientific has a forecasted upside of 267.0% from its current price of $1.09.Amount of Analyst CoverageDanimer Scientific has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted20.87% of the outstanding shares of Danimer Scientific have been sold short.Short Interest Ratio / Days to CoverDanimer Scientific has a short interest ratio ("days to cover") of 19.5, which indicates bearish sentiment.Change versus previous monthShort interest in Danimer Scientific has recently decreased by 3.62%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldDanimer Scientific does not currently pay a dividend.Dividend GrowthDanimer Scientific does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DNMR. Previous Next 3.0 News and Social Media Coverage News SentimentDanimer Scientific has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Danimer Scientific this week, compared to 1 article on an average week.Search Interest17 people have searched for DNMR on MarketBeat in the last 30 days. This is an increase of 240% compared to the previous 30 days.MarketBeat Follows10 people have added Danimer Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Danimer Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders14.30% of the stock of Danimer Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.84% of the stock of Danimer Scientific is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Danimer Scientific are expected to grow in the coming year, from ($1.52) to ($1.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Danimer Scientific is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Danimer Scientific is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDanimer Scientific has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW About Danimer Scientific Stock (NYSE:DNMR)Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.Read More DNMR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DNMR Stock News HeadlinesMarch 28, 2024 | benzinga.comRecap: Danimer Scientific Q4 EarningsMarch 28, 2024 | finance.yahoo.comDanimer Scientific Inc (DNMR) Faces Headwinds: Earnings Miss Analyst Expectations Amidst ChallengesMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…March 28, 2024 | businesswire.comDanimer Scientific Announces Fourth Quarter and Full Year 2023 ResultsMarch 26, 2024 | americanbankingnews.comDanimer Scientific (DNMR) Scheduled to Post Quarterly Earnings on ThursdayMarch 25, 2024 | businesswire.comDanimer Scientific Announces Closing of $15 Million Registered Direct OfferingMarch 22, 2024 | finance.yahoo.comDanimer Scientific Inc (DNMR) Faces Revenue Decline Amidst Growth in PHA SegmentMarch 21, 2024 | markets.businessinsider.comDanimer Scientific: Strong Buy Rating on Positive Growth and Financial Stability ProjectionsMarch 29, 2024 | American Alternative (Ad)Your Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…March 21, 2024 | markets.businessinsider.comDanimer Scientific Announces $15 Mln Registered Direct OfferingMarch 20, 2024 | businesswire.comDanimer Scientific Announces $15 Million Registered Direct OfferingMarch 17, 2024 | finance.yahoo.comDNMR Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comDNMR Apr 2024 1.500 putMarch 15, 2024 | finance.yahoo.comDNMR Mar 2024 1.000 putMarch 10, 2024 | finance.yahoo.comDNMR Mar 2024 1.500 putMarch 8, 2024 | finance.yahoo.comDNMR Aug 2024 2.000 callFebruary 22, 2024 | finance.yahoo.comDanimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant CapacityFebruary 22, 2024 | businesswire.comDanimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant CapacityFebruary 16, 2024 | finance.yahoo.comWhile institutions invested in Danimer Scientific, Inc. (NYSE:DNMR) benefited from last week's 54% gain, individual investors stood to gain the mostFebruary 8, 2024 | benzinga.comDanimer Scientific Stock (NYSE:DNMR) Dividends: History, Yield and DatesJanuary 29, 2024 | finance.yahoo.comDanimer Scientific Receives Continued Listing Standard Notice from NYSENovember 30, 2023 | msn.comDNMR, KGEI and RDHL among pre-market losersNovember 21, 2023 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Danimer Scientific (DNMR)November 19, 2023 | finance.yahoo.comWhat You Need To Know About The Danimer Scientific, Inc. (NYSE:DNMR) Analyst Downgrade TodayNovember 15, 2023 | finance.yahoo.comDanimer Scientific, Inc. (NYSE:DNMR) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | businesswire.com(0.39November 14, 2023 | msn.comDanimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue EstimatesSee More Headlines Receive DNMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danimer Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorIndustrial Products Industry Plastics materials & resins Sub-IndustryN/A Current SymbolNYSE:DNMR CUSIPN/A CIK1779020 Webdanimerscientific.com Phone229-243-7075FaxN/AEmployees271Year FoundedN/APrice Target and Rating Average Stock Price Target$4.00 High Stock Price Target$4.00 Low Stock Price Target$4.00 Potential Upside/Downside+267.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-179,760,000.00 Net Margins-282.18% Pretax Margin-281.64% Return on Equity-42.11% Return on Assets-19.48% Debt Debt-to-Equity Ratio1.24 Current Ratio8.61 Quick Ratio6.80 Sales & Book Value Annual Sales$53.22 million Price / Sales2.09 Cash FlowN/A Price / Cash FlowN/A Book Value$3.71 per share Price / Book0.29Miscellaneous Outstanding Shares102,040,000Free Float87,444,000Market Cap$111.22 million OptionableOptionable Beta1.55 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Stephen E. Croskrey (Age 63)CEO & Chairman of the Board Comp: $887.94kMr. Michael A. Hajost (Age 60)Chief Financial Officer Comp: $393.51kMr. Phillip D. Van Trump (Age 47)Chief Science & Technology Officer Comp: $338.5kMr. Michael Smith (Age 55)Chief Operating Officer Comp: $373.69kRuss ZukowskiVice President of Corporate FinanceJames PalczynskiInvestor Relations OfficerMr. Stephen Albert Martin Esq. (Age 55)Corporate Secretary & Chief Legal Officer Mr. Scott C. Tuten (Age 48)Chief Marketing & Sustainability Officer Comp: $381.64kMr. Anthony L. Austin (Age 66)Chief Human Resource Officer Mr. John A. Dowdy III (Age 51)Senior Vice President of Financial Planning & Analysis Comp: $375.46kMore ExecutivesKey CompetitorsTrinseoNYSE:TSEAdvanced Emissions SolutionsNASDAQ:ADESResearch SolutionsNASDAQ:RSSSAscent IndustriesNASDAQ:ACNTLakeland IndustriesNASDAQ:LAKEView All CompetitorsInsiders & InstitutionsGoldman Sachs Group Inc.Bought 16,994 shares on 3/1/2024Ownership: 0.446%Virtu Financial LLCBought 157,085 shares on 2/26/2024Ownership: 0.178%Nuveen Asset Management LLCBought 30,721 shares on 2/15/2024Ownership: 0.404%GTS Securities LLCSold 8,600 shares on 2/15/2024Ownership: 0.000%Wolverine Trading LLCSold 10,500 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions DNMR Stock Analysis - Frequently Asked Questions Should I buy or sell Danimer Scientific stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danimer Scientific in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DNMR shares. View DNMR analyst ratings or view top-rated stocks. What is Danimer Scientific's stock price target for 2024? 1 Wall Street analysts have issued twelve-month price targets for Danimer Scientific's stock. Their DNMR share price targets range from $4.00 to $4.00. On average, they predict the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 267.0% from the stock's current price. View analysts price targets for DNMR or view top-rated stocks among Wall Street analysts. How have DNMR shares performed in 2024? Danimer Scientific's stock was trading at $1.02 at the beginning of 2024. Since then, DNMR stock has increased by 6.9% and is now trading at $1.09. View the best growth stocks for 2024 here. What ETFs hold Danimer Scientific's stock? ETFs with the largest weight of Danimer Scientific (NYSE:DNMR) stock in their portfolio include Putnam BioRevolution ETF (SYNB).Goldman Sachs Future Planet Equity ETF (GSFP). What guidance has Danimer Scientific issued on next quarter's earnings? Danimer Scientific updated its fourth quarter 2023 earnings guidance on Wednesday, March, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $10.9 million-$10.9 million, compared to the consensus revenue estimate of $11.6 million. Who are Danimer Scientific's major shareholders? Danimer Scientific's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Greenlight Capital Inc. (2.68%), Royal Bank of Canada (0.70%), Northern Trust Corp (0.67%), Charles Schwab Investment Management Inc. (0.62%), Goldman Sachs Group Inc. (0.45%) and Goldman Sachs Group Inc. (0.45%). Insiders that own company stock include Richard J Hendrix, Scott Tuten and Stuart W Pratt. View institutional ownership trends. How do I buy shares of Danimer Scientific? Shares of DNMR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:DNMR) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danimer Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.